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This paper reports on a review of the literature in liposuction for women with 
lipoedema and those with Dercum’s disease. The aims were: to identify the 
outcomes from liposuction in these two groups and describe adverse effects 
reported in the studies. A total of 10 studies met the inclusion and exclusion criteria, 
dated between 2006-2019. Improvements in pain, quality of life and mobility were 
common outcomes. There were indications that reliance on conservative treatments 
reduced after liposuction. The incidence of adverse effects appeared modest, 
including minor haematomas, postoperative swelling, orthostatic reactions, 
temporary bruising and burning sensations. However, the numbers studied were 
relatively small, particularly relating to Dercum’s disease. Findings were limited by 
retrospective evaluations, use of poorly validated tools, and relatively short follow-up 
periods in some studies. There were no randomised controlled trials. Lack of 
standardisation made it challenging to analyse and compare outcomes across 
different studies. Liposuction appears to play a role as a treatment option for some 
women in managing symptoms, however, further research is required to better 
explore efficacy and cost-effectiveness, monitor adverse effects, inform decision-
making and identify key advice for women who undergo liposuction. 
 
Introduction 
Liposuction is a surgical option in the management of fat disorders such as 
lipoedema and Dercum’s disease (Box 1) (Lontok 2017; Wounds UK 2017), 
particularly where there has been inadequate response to conservative therapy 
(Halk and Damstra 2016).  Liposuction is not a cure for lipoedema and is not suitable 
for everyone.  However, faced with debilitating symptoms such as pain, poor 
mobility, and the distress of appearance changes (Dudek et al. 2018), many women 
seek liposuction in conjunction with self-management approaches. Some travel 
within Europe for private treatments, as there are very limited opportunities for 




The pathogenesis of lipoedema is not fully understood, but may include capillary 
fragility, angiogenesis, inflammatory processes and impairment of lymphatic function 
(Okhovat and Alavi 2015). Conservative therapies provide opportunity to optimise 
health and manage symptoms (Wounds UK 2017). However, it is important to review 
the evidence for surgical treatment options such as liposuction, and identify any 
adverse effects reported in the literature. 
 
Background to liposuction 
Liposuction, first introduced as a surgical procedure in the mid-1970s (Rapprich et al 
2012; Bellini et al 2017), is the suction-assisted removal of excess epifascial 
subcutaneous adipose tissue via a cannula inserted through small incisions in the 
skin (Shridharani et al 2014). Also referred to as lipectomy or lipoplasty, it is one of 
the most commonly performed aesthetic procedures, and is also used in various 
medical conditions (Table  2).  In a survey of 250 women with lipoedema, 7.6% had 
undergone liposuction, with 74% of those women reporting it as ‘effective’ (Fetzer 
and Fetzer 2016).  
 
Types of liposuction used in lipoedema include: 
 Tumescent liposuction: large amounts of solution containing anaesthetic are 
introduced into the area to cause numbing, constrict blood vessels, and 
separate the fat and connective tissue (Lontok et al 2017). 
 Water-assisted liposuction: small amounts of tumescent solution are inserted 
and a water jet is used to separate the fat tissues while detached cells and 
solution are aspirated (Lontok et al 2017). 
 Suction-assisted dry liposuction under tourniquet (Warren Peled et al 2012).  
 
Criteria for liposuction in lipoedema 
Surgical teams vary in their approaches, and there are no consistent or standardised 
criteria regarding suitability for liposuction in lipoedema within the current literature.  
However, a key focus is on removing excess fatty tissue, where there is little or no 
pitting oedema, in order to improve pain, function and mobility (Forner-Cordero et al 
2012). In managing lipoedema, the legs, arms, buttocks and abdomen are commonly 
treated areas, with multiple operations usually required (Forner-Cordero et al 2012). 
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The operation, depending on circumstances, may be under local or general 
anaesthetic, and it can take around 2-4 hours for around 6-7 litres of fat to be 
removed from a leg.   
 
Review process 
Aims of the review 
The key aims were to analyse the evidence to: 
1. Identify the outcomes for liposuction in women with lipoedema and Dercum’s 
disease. 
2. Describe adverse effects reported in the studies. 
 
Search strategy 
Databases searched: Medline; CINAHL; Pub Med.  Reference lists of papers and 
best practice guidelines were also scrutinised for further research evidence. Search 
terms included: lipoedema or lipedema or Dercum’s disease combined with 
liposuction; lipoplasty; lipectomy; tumescent; adverse effects.  The inclusion criteria 
were papers published in English that were research studies of liposuction.  
Exclusion criteria were papers focussing on lymphoedema; ‘cankle’ surgery not 
identified as lipoedema; single case study reports; bariatric surgery; and histologic 
analyses.  
 
A total of 177 papers were identified in the search. When inclusion and exclusion 
criteria were applied, this was reduced to 10 papers suitable for the review.  A 
modified critical appraisal tool (CASP 2019) was used for data extraction. 
 
Review findings 
Outcomes of liposuction 
A group from the Hanse-Klinik in Lübek, Germany, reported the first study of 
liposuction in women with lipoedema, which aimed to determine the efficacy and 
safety in relation to appearance and associated complaints (Schmeller and Meier-
Vollrath 2006).  Between 2002 and 2005, 28 women with lipoedema (mean age 37.7 
years), who previously had conservative treatments for many years, were treated by 
tumescent liposuction, with local anaesthesia.   
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A total of 49 operations were performed, with a mean 3,017 mls removed in each 
session.  Twenty one patients were evaluated post-operatively between 1 to 26 
months (mean 12.2 months). The authors commented that: ‘all experienced a 
satisfactory, often dramatic, improvement in body proportions’ (Schmeller and 
Meirer-Vollrath 2006, p8). Of the 18 patients experiencing pain before surgery, 16 
(89%) experienced improvement in pain. Improvements in sensitivity to pressure, 
oedema, bruising and quality of life were also recorded, although no measurement 
tools or statistical analysis were applied.  The authors identified that physiotherapy 
and compression were still required following surgery, and did not report any 
adverse effects from liposuction. 
 
In a subsequent publication, Schmeller et al (2012) reported findings from a 
questionnaire completed by 112 patients who underwent a total 349 tumescent 
liposuction sessions between 2003 and 2009 at the Hanse-Klinik.  The women were 
between 1 year 1 month and 7 years 4 months (mean 3 years and 8 months) since 
their first liposuction surgery, with 100 of these patients operated on more than once; 
a mean 3,077mls (range 450-7,000mls) of fat was removed per session. The seven-
item instrument developed for the study used a five-point scale (0-4) to evaluate 
seven complaints: spontaneous pain; sensitivity to pressure; oedema; bruising; 
restriction of movement; cosmetic appearance; and reduction in quality of life.   It 
also provided a mean total score of general impairment with data subjected to t-tests 
and analyses of variances.   
 
The authors reported a statistically significant improvement in mean scores for all 
seven items (p=<0.001) with the highest scores in effect size being seen in improved 
cosmetic appearance and quality of life. When general impairment was analysed 
according to age, stage of lipoedema, and time since surgery, those with stage 2 and 
3 lipoedema (77 of the total group), appeared to have a greater improvement 
compared to those with stage 1.  A total of 93 of the 112 patients (83%)  had 
undergone conservative treatment such as manual lymph drainage and/or 
compression prior to surgery, with 22.4% no longer using any conservative treatment 




Baumgartner et al (2015) further followed up 85 of the 112 patients evaluated in the 
above study, using the same questionnaire mailed to the women in 2014, and 
provided some evidence for the long-term outcomes of liposuction.  At this second 
follow up point, the average age of the women was 47.4 years, with follow up taking 
place a mean 7 years and 6 months since their last surgery.   The scores for the 
seven items remained significantly lower than before liposuction, but there was a 
slight increase in impairments in all scales, and for overall impairment, from the 
previous study time point.  The increases in bruising, restricted movement, cosmetic 
impairment and impaired quality of life were all statistically significant (p < 0.5) but 
identified as not clinically relevant by the authors.  
 
Quality of life and reduction in overall impairment both remained improved from pre-
liposuctions levels. Analysis using two-way analysis of variances (ANOVAS) showed 
that age was insignificant for effectiveness of the intervention. The authors 
suggested that greater improvement in overall impairment occurred in those with 
stage 2 lipoedema compared to those with stage 1.  Of the 47 patients included in 
this study that were using conservative treatments pre-operatively, 30% no longer 
required these, 60% used them less frequently, and 10% used them as before. 
 
Another German team (Rapprich et al 2010) reported on a study of 25 patients with a 
mean age of 38 years (range 22-65) who were followed up six months after their last 
liposuction procedure in a dermatology unit.  Leg volumes were recorded using 3D 
imaging, and patients undertook self-assessment of symptoms using a quality of life 
tool (FLQA-1) (Augustin et al 2005) before surgery and six months after their last 
surgery.  Liposuction was performed using tumescent local anaesthesia with 
vibrating cannulae, and 23 underwent this as an outpatient procedure. Patients had 
one to five sessions (mean 2.5 +/- 1.1) treating thighs, knees, hips and lower legs, 
with three days antibiotic prophylaxis. Those having lower limb liposuction had 
compression therapy for 2-3 days after surgery; and all were advised to wear 
compression stockings for 4-6 weeks after surgery.  However, there is no record of 
how consistently these were worn. 
 
The 3D imaging showed a reduction in leg volume of between 0.9 and 4 litres (mean 
1.2 +/- 1.01 litres).  Fifteen symptom parameters were assessed: pain; sensitivity, 
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bruising, tension; warmth; cold; muscle cramp; heavy legs, tired legs, swelling; skin 
involvement, itching; difficulty walking; affect on quality of life; and satisfaction with 
appearance. The authors suggested there was a highly significant improvement in 
pain (p < 0.001), sensitivity to pressure and quality of life, although statistical details 
were not reported for all parameters. The scores were combined for a total possible 
score of 150, and a 58% improvement in total mean score (p < 0.001) reported.   
Regarding conservative treatments, 15 patients had received treatments pre-
operatively with two (8%) continuing this post-operatively. While 76% of patients had 
worn compression therapy prior to surgery, only 16% reported still using 
compression therapy six months post-operatively.  
 
The authors suggested that manual lymph drainage and compression therapy are an 
essential part of the healing process and treatment success, indicating that use of 
compression therapy may be lifelong.  They also cautioned that while liposuction 
removes fatty tissue, lipoedema may continue to progress, suggesting that the follow 
up period of six month is too short to assess long term outcomes or recurrence. 
 
A third team from Germany reported a series of studies of liposuction in women with 
lipoedema. Wollina et al (2010) described their evaluation of outcome and risks from 
tumescent liposuction in two women with lipoedema, and four women with Dercum’s 
disease between 2004 and 2008. All six women had previously undergone 
conservative therapy with manual lymph drainage and compression garments; they 
all wore a compression garment for at least six months following surgery. One was 
treated as an outpatient, and the others were in-patients.  All had local tumescent 
anaesthesia with liposuction performed over a series of one to four sessions, with 
500-1800mls removed at each session. Satisfaction was recorded as: unsatisfied; 
unchanged; medium; high; to very high.  Follow up at six months indicated high or 
very high satisfaction in five patients, and the authors reported reduced pain in three 
of those with Dercum’s disease. 
 
In a later paper, Wollina et al (2012) reported outcomes from 24 consecutive adult 
patients with painful lipoedema, and two with Dercum’s disease. They were treated 
between 2005 and 2011, firstly with conservative decongestive therapy (manual 
lymph drainage and compression therapy), and then liposuction.  During the study 
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period, the team moved from using microcannular tumescent liposuction (for 43 
sessions) to laser-assisted tumescent liposuction (for 22 sessions), with each patient 
undergoing between one to four sessions. The scoring system reported in the paper 
indicated that liposuction improved pain, mobility, bruising and self esteem more 
effectively than conservative therapy, although statistical analyses were not 
provided. 
 
A more recent paper reported on 111 patients with a median age of 44 years, treated 
between 2007-2018, with tumescent liposuction (Wollina et al 2019). This group 
included 21% of patients with a co-morbidity of ‘obesity’ and 11% with lymphoedema 
secondary to lipoedema.  The mean total aspirate per patient was 4,700+/-7,579mls, 
and a median 6cm reduction in limb circumference was reported. A 10-point visual 
analogue scale recorded changes in pain, and a 3-point scale used to measure 
changes in bruising and mobility.  Two-tailed Mann-Whitney U tests, used to analyse 
differences before and after treatment, showed statistically significant improvements 
in pain after liposuction (p < 0.3).  An improvement in mobility was achieved in 100% 
and a marked improvement in/complete loss of impairment in 86% patients. 
Improved perception of mobility was reported by 100%, tendency to bruising on 
minor trauma improved in 50%, with a further 16.4% of patients no longer requiring 
conservative therapy.   
 
Dadras et al (2017) aimed to determine the outcome of tumescent liposuction in 25 
women with lipoedema who underwent a total of 72 liposuction procedures. This was 
a retrospective evaluation using an 18-item questionnaire incorporating visual 
analogue scales to assess the severity of spontaneous pain, pain upon pressure, 
feeling of tension, bruising, cosmetic impairment, and general impairment of quality 
of life.  The questionnaire was completed by all patients at the end of 2013 and again 
in 2015.  A mean 3,106 mL (range, 1,450–6,600 mL) of fat was removed at each 
session. The authors reported a reduction in spontaneous pain and in impairment of 
quality of life at the first post-operative time point, and significant improvement in all 
symptoms between the preoperative period and the second postoperative follow-up. 





Hansson et al (2011) in a study of 53 patients with Dercum’s disease, aimed to 
assess the effect of liposuction on pain experiences. All participants completed 
questionnaires pre-operatively, at 3 months, 1, 2, 3 and 5 years which incorporated: 
a visual analogue scale to record changes in quality and intensity of pain; and a 
number-of-words scale incorporating 12 sensory and 11 affective pain descriptors, 
adapted from the McGill pain questionnaire.  An objective measure using a locally 
constructed and validated algometer designed to measure mechanical pressure pain 
threshold was also used to gather data at the same time points.  
 
The average amount of fat removed in the liposuction group was 3,749 +/- 2,325 
grams. Both objective and subjective pain measures revealed reduced pain post-
operatively, although the improvement faded over time, but did remain statistically 
significant at 5 years (p = <0.001). The authors discussed various mechanisms for 
pain in Dercum’s disease including central and peripheral nervous system 
aetiologies, and identified the challenges of measuring changes in pain, suggesting 
that further randomised trials are required. 
 
Adverse effects 
From the 349 liposuction sessions reported by Schemeller et al (2012), five patients 
(1.4%) developed a post-operative wound infection, despite all receiving 3 days of 
post-operative antibiotics. One had developed an abscess that required hospital 
admission. One woman had post-operative haemorrhage with lowered haemoglobin 
levels returning to normal within four weeks. The authors also recorded minor 
haematomas, post-operative swelling, orthostatic reactions on the day of surgery, 
and indurations in the leg tissues that disappeared within weeks, although there are 
limited details in the papers.  
 
Wollina et al (2010) reported an increase in haemoglobin levels in one patient, and 
infection with raised body temperature and leucocytosis in one patient, one instance 
of bleeding from varicose veins, and skin laxity that required further surgery in two 
patients >65 years.  A later paper (Wollina et al 2019) also reported fat embolism 
(n=1), pulmonary oedema (n=1), phlebitis (n=1), temporary bruising and burning 




The study by Rapprich et al (2010) reported one incidence of deep vein thrombosis 
of the lower leg. However, there were no indications of other complications or 




This review provides some evidence for liposuction in lipoedema and Dercum’s 
disease.  Improvements in pain, quality of life and mobility appear to be common 
outcomes, along with reduced reliance on conservative therapies. This suggests that 
liposuction may offer symptom management with the physical and psychological 
effects of lipoedema. It may also reduce the need for long-term decongestive 
conservative treatments, although more research is required to assess efficacy and 
cost-effectiveness of liposuction.   
 
However, the numbers studied remain relatively small, particularly in relation to those 
with Dercum’s disease. Findings are limited by retrospective evaluations, use of 
poorly validated tools, and relatively short time points for measuring outcomes, 
making it challenging to assess the long term effect on limb size and symptoms. To 
date there have been no randomised clinical trials, and there is limited 
standardisation in the research designs, making it challenging to assess and 
compare outcomes across the various studies.  Further, the literature does not 
provide robust evidence to inform suitability criteria for liposuction, nor what groups 
may benefit most from this approach. There is some indication that those with stage 
2 or 3 lipoedema had better outcomes than those with early lipoedema, although it is 
likely that the latter group initially presented with less severe symptoms. Outcomes 
measures may lack sensitivity in terms of measuring the less obvious changes 
experienced by those with early lipoedema. There remains limited evidence to inform 
post-operative care, such as the use of compression therapy or manual lymph 
drainage in the immediate and longer post-operative period.  
 
The incidence of adverse effects appears relatively modest, although it is difficult to 
comment on the extent of these problems are these is no standardisation in the 
reporting.  Schmeller and Meier-Vollrath (2007) suggested that current anaesthetic 
and surgical techniques result in improved outcomes for liposuction in lipoedema, 
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with limited lymph vessel damage (Stutz and Krahl 2009).  Warren Peled et al (2012) 
also provided some evidence that lymphatic function is not compromised by 
liposuction.   This may explain why there was no report of lymphoedema developing 
after liposuction.  
 
A further review of non-English language literature would be useful.  Future research 
to evaluate the outcomes and adverse effects in larger groups, using validated tools, 
is required to inform decision-making regarding liposuction in lipoedema, and identify 
key advice for women who undergo this treatment.  
 
Box 1: Definitions of lipoedema and 
Dercum’s disease 
Lipoedema: characterised by a symmetrical 
distribution of fat which is often painful and 
nodular, with fat lobes developing particularly 
in the limbs, leading to difficulties with 
movement (Wounds UK 2017).  
 
Dercum’s disease (adiposis dolorasa): 
similar presentation and symptoms to 
lipoedema but rare (Lontok 2017); 





Box 2: examples of medical conditions 
suitable for liposuction (Shrisdharani et al 
2014; Bellini et al 2017) 
 Lipoedema 
 Lymphoedema 
 Leakage around stoma sites due to 
bugling fatty skin fold 
 Fatty areas due to insulin injection 
 Multiple familial angio-lipomatosis 
 Gynaecomastia 
 Benign symmetrical lipomatosis 
 Retroviral medication-induced 
lipodystrophy 
 Steroid-induced Cushing’s disease 
 Post bariatric body contouring 
 Scar revision 
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